Substance / Medication

Hydroquinone monobenzyl ether

Overview

Active Ingredient
monobenzone
RxNorm CUI
17145

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

13 trials linked to this intervention

13
Total Trials
5
Recruiting
0
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Efficacy of Janus kinase inhibitor combined with phototherapy in non-segmental vitiligo: systematic review and meta-analysis.
Shuaib Laiba, D Rai Kuldeep, K Sangtiani Aneesh et al. · Ann Med · 2026
PMID: 41454839Meta-AnalysisFull text (PMC)
Excimer 308-Nm Light in the Combination Treatment of Vitiligo: A Systematic Review and Network Meta-Analysis.
Liu Zhengyang, Ng Wey Han, Morriss Samuel et al. · Pigment Cell Melanoma Res · 2026
PMID: 41564112Meta-Analysis
Co-Occurrence of Inflammatory Bowel Disease in Patients with Vitiligo: A Systematic Review and Meta-Analysis.
Gu Zhaoyi, Teng Jingjing · Turk J Gastroenterol · 2026
PMID: 41578766Meta-AnalysisFull text (PMC)
Predictors and mechanisms of self-stigma in five chronic skin diseases: A systematic review.
Stuhlmann Caroline F Z, Traxler Juliane, Paucke Valentina et al. · J Eur Acad Dermatol Venereol · 2025
PMID: 39247975Meta-AnalysisFull text (PMC)
Effectiveness and Tolerability of Various 5-Fluorouracil Formulations as Adjuvant Therapies for Vitiligo Management: A Systematic Review and Meta-Analysis.
Kohaf Neveen A, Sarsik Sameh M, Salman Samar et al. · Curr Rev Clin Exp Pharmacol · 2025
PMID: 39428927Meta-Analysis
Efficacy and Safety of Janus Kinase Inhibitors in Patients with Vitiligo: A Systematic Review and Meta-Analysis.
Huang Fan, Hu Dingyuan, Fan Huaying et al. · Clin Pharmacol Ther · 2025
PMID: 39713946Meta-AnalysisFull text (PMC)
Vitiligo and the microbiome of the gut and skin: a systematic review.
Nigro Alexandra, Osman Alim, Suryadevara Pavan et al. · Arch Dermatol Res · 2025
PMID: 39777551Meta-Analysis
Stable vitiligo treated by transplantation of autologous melanocytes: a meta-analysis.
Cao Xue, Zhang Wentao, Jia Zhongyuan et al. · Arch Dermatol Res · 2025
PMID: 39891763Meta-Analysis
Off-label use of JAK1 inhibitor upadacitinib in dermatology.
Zhang Tian-Yi, Zeng Yue-Ping · Arch Dermatol Res · 2025
PMID: 39920358Meta-Analysis
Relative Impact of Monotherapies for Vitiligo: A Network Meta-Analysis Study.
Gupta Aditya K, Bamimore Mary A, Seneschal Julien et al. · J Cosmet Dermatol · 2025
PMID: 40013382Meta-AnalysisFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Monobenzone (substance)
SNOMED CT
256167003
UMLS CUI
C0050962
RxNorm CUI
17145

Clinical Data

This intervention maps to 1 entities in the Healos knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
13
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.